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One sentence summary: The authors review currently applied collection and preservation methods for gut microbiome research, discussing aspects
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Project, a large-scale gut microbiome sampling effort in Belgium, to give an idea of perspectives, and pitfalls of population-wide studies implementing




First insights on the human gut microbiome have been gained from medium-sized, cross-sectional studies. However, given
the modest portion of explained variance of currently identified covariates and the small effect size of gut microbiota
modulation strategies, upscaling seems essential for further discovery and characterisation of the multiple influencing
factors and their relative contribution. In order to guide future research projects and standardisation efforts, we here review
currently applied collection and preservation methods for gut microbiome research. We discuss aspects such as sample
quality, applicable omics techniques, user experience and time and cost efficiency. In addition, we evaluate the protocols of
a large-scale microbiome cohort initiative, the Flemish Gut Flora Project, to give an idea of perspectives, and pitfalls of
large-scale faecal sampling studies. Although cryopreservation can be regarded as the gold standard, freezing protocols
generally require more resources due to cold chain management. However, here we show that much can be gained from an
optimised transport chain and sample aliquoting before freezing. Other protocols can be useful as long as they preserve the
microbial signature of a sample such that relevant conclusions can be drawn regarding the research question, and the
obtained data are stable and reproducible over time.
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INTRODUCTION
In recent years, the human gut microbiota (the collective mi-
crobial content of the intestinal tract) has emerged as a pri-
mary target area for healthmonitoring andmodulation (Cho and
Blaser 2012; Lozupone et al. 2012). Alterations in the gut micro-
biota have been linked repeatedly to pathological states such
as infections, autoimmune disorders, inflammatory bowel dis-
eases and cancer. Aside from these pathologies, accumulating
evidence suggests that gut microbiota composition can serve as
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indicator of chronic suboptimal health andwell-being: either di-
rectly linked to suboptimal bowel functioning (e.g. bloating, flat-
ulation, constipation) or extended to general health (Claesson
et al. 2012; Koboziev et al. 2014) (e.g. chronic undefined inflam-
mation (Lozupone et al. 2012; Le Chatelier et al. 2013), anxiety
and stress (Cryan and Dinan 2012)).
The first major insights on disease-associated microbiome
variation have been gained from targeted, medium-sized
(N < 400), cross-sectional studies (Koren et al. 2013; Le Chate-
lier et al. 2013). Many of these early studies collected only lim-
ited additional data on the study subjects (e.g. food habits, clini-
cal parameters) and were often single centre-based or restricted
to certain populations (e.g. US or Chinese citizens). However,
to effectively tackle health monitoring and modulation through
the gut microbiota, substantial targeted research efforts are re-
quired (Debelius et al. 2016; Falony et al. 2016).
First, larger, representative population cohorts need to be
screened in order to pick up relevant microbiome signals be-
yond multiple expected confounding factors. Many parameters
have already been reported to influence gut microbiota compo-
sition, ranging from host genotype (Frank et al. 2011), nutrition
(Kau et al. 2011), inflammation (Cani et al. 2008) and antibiotic us-
age (Lozupone et al. 2012) to stool consistency (Vandeputte et al.
2016), but this list is still expanding and the relative importance
of these and other unknown factors remains unclear. It has be-
come obvious that upscaling is required to disentangle the mul-
tiple, confounding effects in the high-dimensional microbiome
data (Raes, Foerstner and Bork 2007; Caporaso et al. 2011).
Second, only a longitudinal study design allows encompass-
ing the dynamic nature of these factors and the identification
of microbiome-based prognostic signals and markers. To fur-
ther study the temporal stability of the gut microbiota, it is
also crucial to collect samples over time. The historical lack of
sufficiently powered, comprehensively phenotyped, longitudi-
nal studies leads to the baffling observation that it is still unclear
what defines a dysbiotic gut microbiota. Recent findings remain
conflicting (Finucane et al. 2014), suggesting that there are still
unknown confounders blurring research results or, alternatively,
that multiple unhealthy microbiome states, in conjunction with
host parameters, could be associated to suboptimal health and
ultimately disease.
The longitudinal screening of large, representative popula-
tion cohortsmakes it possible to identifymicrobiome confound-
ing factors together with their relative contribution and to de-
fine dysbiotic or suboptimal microbiome states. Given the high
interest of the general public for microbiome research, the op-
portunities to set up citizen-based studies are ample. However,
design of such studies implies substantial logistic and financial
challenges imposed not only by the required scale but also by
the nature of the sampled material. Ideally, faecal material in-
tended for microbiome monitoring needs to be frozen imme-
diately after sampling in order to stop the growth of residing
bacteria and potential contaminants and to conserve baseline
microbial abundances. Subsequently, samples should be stored
at –80◦C until DNA extraction (Bahl, Bergstro¨m and Licht 2012;
Cardona et al. 2012; Santiago et al. 2014). As sampling is often
performed in the comfort of the participants’ home, the latter
could cause a significant logistical burden. Furthermore, faecal
microbiome monitoring efforts risk to suffer from selection bi-
ases and drop-out associated to personal aversion towards fae-
cal sampling—especially when sampling procedures are experi-
enced as overly laborious (Sackett 1979; Jordan et al. 2013). The
substantial logistical expenses associated to freezing protocols
and concerns about ease and user friendliness of faecal sam-
pling has led to awide range of sampling protocols (both freezing
and room temperature(RT)based), all intended to simplify this
process. However, given the differential lysis sensitivity between
gram-positive and gram-negative faecal bacteria (Wada et al.
2012) and the fact that cell-free DNA can be degraded through
oxidation, hydrolysis and enzymatic degradation (Lindahl 1993),
sampling collection and preservation methods are thought to
have a profound effect on the outcome of sequencing-based
technologies used for microbiome determination (Cardona et al.
2012; Gorzelak et al. 2015). Although the variation induced by
collection and preservation conditions does not overcome in-
terindividual variation, these kinds of technical sources of vari-
ation often do have sizeable effects on the structure of the mi-
crobial community when compared to other biological factors
(Debelius et al. 2016). Such deviations from the original micro-
biome composition limit the discovery of relevant biological ef-
fects and the possibilities for interstudy comparisons or meta-
analyses (Gorzelak et al. 2015; Debelius et al. 2016). Method stan-
dardisation would therefore greatly benefit the field: it would fa-
cilitate robust biological conclusions and their translation into
medicine. Several standardisation efforts to identify sources of
lab-to-lab variation and propose standard processing pipelines
have already been initiated (Aagaard et al. 2013; Dubilier, Mcfall-
ngai and Zhou 2015; The International HumanMicrobiome Con-
sortium 2015).
In order to guide future faecal microbiome research projects
and standardisation efforts, we here review currently ap-
plied collection and preservation methods. Despite the impor-
tance of downstream processing, we only discuss this first
step in microbiome monitoring, as it has been shown to
have a profound effect on the microbial community and dic-
tates which omics techniques can be applied (Cardona et al.
2012). We start with an overview of preservation methods and
their effect on the observed microbial composition. Next, we
elaborate on user experience of faecal sampling and factors af-
fecting drop-out. Lastly, we check time and cost-efficiency of
pre-processing pipelines, covering sample collection, transport
and aliquoting. This last section includes an overview of fae-
cal sample collection options and transport chains. We illus-
trate several aspects using our experience in one of the largest
microbiome cohort initiatives to date—the Flemish Gut Flora
Project (FGFP)—andwith this hope to give the reader an overview
of options and pitfalls of large-scale faecal sampling for gut
microbiota research.
CURRENT OPTIONS FOR FAECAL SAMPLE
PRESERVATION
The first consortia that sequenced the gut microbiota on a (at
that point) large scale opted for freezing whole faecal sam-
ples as soon as possible at –80◦C—either after storage in par-
ticipants’ home freezers (MetaHIT) (Qin et al. 2010) or in an
isolated box with cooled gel packs for a max of 24 h (HMP)
(Gevers et al. 2012). Since then a multitude of alternative sam-
pling and storage methods have been developed in order to
increase user experience or to allow more flexible transport
schemes. Instead of immediate freezing, samples are stored at
4◦C or RT for several hours, days or even weeks, with or with-
out stabilisation buffer. Here, we will discuss a selection of some
of today’s most popular alternatives, each with their respective
practical advantages and disadvantages (Table 1). Please note
that perhaps the most important aspect—the effect of using
these methods on the derived microbiota profiles—is discussed
in a separate section.
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Table 1.Overview of applicable omics techniques, advantages and disadvantages, and a quality assessment of the observedmicrobiome compo-
sition of currently used or tested sample preservation options based on our interpretation of the significant effect of different storage methods
from Table 2, with the advised storage period.
∗Assessment based on the information from Table 2.
aTedjo et al. (2015); bChoo, Leong and Rogers (2015); cGratton et al. (2016); dCarroll et al. (2012); eGorzelak et al. (2015); fDominianni et al. (2014); gReck et al. (2015); hHale
et al. (2015); iFranzosa et al. (2014); jLoftfield et al. (2016); kSong et al. (2016); lAnderson et al. (2016); mGuo et al. (2016); nVogtmann et al. (2016); oSinha et al. (2015); pShaw
et al. (2016); qBlekhman et al. (2016); rHill et al. (2016).
Keep it cool
When immediate preparation or freezing of a faecal sample is
not possible, refrigeration (4◦C) can bridge the time between col-
lection and processing. The lower temperature slows down bac-
terial growth and thus limits deviations from the original com-
position of the egested stool. Samples processed within 24 h
have been shown to be suited formetagenomics analyses (Choo,
Leong and Rogers 2015; Tedjo et al. 2015). However, for metatran-
scriptomic analyses, a stabilisation agent is generally advised in
addition to the cooled storage (Reck et al. 2015). As refrigeration
also slows down fermentation reactions, it allows subsequent
metabolomic analyses with lower differences compared to the
original sample. However, storage time should in this case be re-
stricted to 2 h and one has to be aware that volatile components
will have been lost (Gratton et al. 2016).
Stabilise it
The possibility to store samples for several days or weeks at
RT allows cheaper logistic solutions and much more flexibil-
ity. Hence, several stabilisation buffers have been explored in
the hope of reducing the induced variation in microbiota com-
position. Such solutions however induce lysis of bacterial cells,
and consequently these methods are not suitable for combined
culture-based approaches, which are rapidly gaining impor-
tance for follow-up functional studies.
The commonly usedTris-EDTA-buffer, which is used to sol-
ubilise purified DNA or RNA, protecting those from nucle-
ase activity, was one of the first methods investigated (Choo,
Leong and Rogers 2015). This buffer contains Tris, a pH buffer,
and EDTA, a cation-chelating agent, and is highly effective
in preventing nucleic acid degradation. Although faecal sam-
ples stored at RT in Tris-EDTA buffer render sufficient high
molecular weight DNA to allow 16S rRNA microbiota profil-
ing and shotgun metagenomic sequencing, there is no guaran-
tee that the obtained DNA reflects the original microbial com-
munity present in the stool sample (Choo, Leong and Rogers
2015), making its use in metagenomic analyses thus doubt-
ful. Other -omics techniques are generally not applied with
this buffer.
Another obvious candidate for microbiome stabilisation pur-
poses is theRNAlater solution. This buffer was originally de-
veloped to protect RNA of small tissue or blood samples from
degradation by inactivating RNases. However, it is also pos-
sible to extract genomic DNA from RNAlater stored samples,
thus opening up opportunities for RT storage of faecal sam-
ples intended for microbiome research. Samples stored with
RNAlater indeed yield sufficient DNA formetagenomic analyses,
although both DNA quantity and purity are lower when com-
pared to other storage methods (Dominianni et al. 2014; Gorze-
lak et al. 2015). As RNAlater is supposed to stabilise RNA, tran-
scriptomic analyses are in theory an option as well. Although
high-quality RNA can be obtained from faecal samples stored
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at RT in RNAlater for up to 6 days, the reagent has been shown
to introduce a bias in the mRNA profile, possibly dependent on
the abundance of the resident species (Reck et al. 2015). Protein-
based techniques are not feasible given the induced protein
degradation, nor are metabolomics due to the storage temper-
ature and buffer (Vuckovic 2012). Proper stabilisation of the nu-
cleic acids requires RNAlater to rapidly penetrate the sample,
making small sample sizes and large amounts of reagent nec-
essary. In general, a 1:5 ratio sample to RNAlater volume is
recommended. With the current pricing of RNAlater (about 1
€/ml), this requirement makes the collection of larger amounts
of sample (e.g. for biobanking) cost-prohibitive and compli-
cates the logistics by substantially increasing the required
storage space.
Ethanol, widely used in zoology as a medium for tissue con-
servation, was also investigated early on for its stabilising prop-
erties. Optimal DNA preservation is obtained with ethanol con-
centrations of 95%–99% using a volumetric ratio of 5:1 or higher.
Pure ethanol is not recommended as it can contain traces of
benzene, seriously affecting DNA integrity, while higher dilu-
tions lead to higher degradation rates (Prendini, Hanner and De-
Salle 2002; Nagy 2010). Although ethanol is considerably cheaper
than RNAlater (5–10 €/l), it is clear that given the volumet-
ric ratios recommended, it suffers from the same drawbacks
regarding storage space. Furthermore, care needs to be taken
that the ethanol does not evaporate and as ethanol is not only
volatile but also flammable, it is considered hazardous and ship-
ping costs increase accordingly (Nagy 2010; Song et al. 2016).
Faecal samples stored under various dilutions of ethanol, with
or without a subsequent lyophilisation step, were shown to be
suited for genomic DNA as well as steroid hormone analyses
(Murphy 1990; Khan et al. 2002; Nsubuga et al. 2004). However,
removal of the ethanol prior to DNA extraction is required. This
can be achieved using silica beads or drying at a temperature
below 60◦C for several minutes (Nsubuga et al. 2004; Nagy 2010).
DNA/RNA quality of ethanol stored faecal samples is sufficient
for metagenomic and metatranscriptomic analyses (Franzosa
et al. 2014) as well as other omics assessments (Loftfield et al.
2016). However, culturing procedures are excludedwith ethanol-
based protocols (Tapani et al. 1996).
Room temperature transport vials (RTTVs) are all in one
systems for easy collection and stabilisation of microbial DNA
from faeces. The currently available RTTV OMNIgeneGUT re-
quires the participant to transfer a faecal sample of around
500 mg to an opened tube with a spatula. The sample is then
forced through a filter by closing the tube with a screw cap. The
sample is homogenised immediately in the stabilising buffer
by shaking it vigorously for at least 30 s. In this way, partici-
pants thus assist in aliquoting and homogenisation, although
they do not possess any lab equipment or skills. Consequently,
there is a risk that these processes might not completely meet
lab standards. Obviously, all participant-dependent methods
suffer from this drawback to some extent. According to the
manufacturer, storage in OMNIgeneGut tubes maintains the
original microbiota composition at RT for up to 60 days and
renders high-quality DNA suitable for metagenomic analyses
(http://www.dnagenotek.com). DNA and RNA yields are indeed
high, and were even reported to exceed those of frozen sam-
ples (Anderson et al. 2016). Yet, the reported 74% and 1000%
increases in respectively DNA and RNA are probably overesti-
mations, as dilution differences between fresh and frozen sam-
ples were not taken into account (Anderson et al. 2016). Current
RTTVs are not suited for proteomic, metabolomic or culturing
approaches.
Take it easy
While the methods described above mostly try to reduce devia-
tions from the original microbiota composition (with increased
logistic costs), others, such as swab and card-based protocols,
are more directed towards facilitating the sampling process for
study participants.
Faecal swabs quickly entered the field of gut microbial re-
search because of their user friendliness: participants only have
to dip a swab into the collected faeces and put it into a tube.
Swabbing can be combined with any of the preservation meth-
ods described above, but the tiny amounts of collected sample
as well as the storage matrix cause some additional drawbacks
(see below).
Most of the commercially available swabbing kits are used
for the detection of enteropathogens and use media developed
to make culturing of the resident bacteria possible (e.g. Cary-
Blair medium) (Tedjo et al. 2015). Although these kits make it
possible to use the obtained samples for all omics techniques as
well as culturing, overgrowth of gram-negative (Proteo-)bacteria
is very likely. Furthermore, the preservation medium dilutes the
already small amount of sample, DNA yields are generally low
and an adapted DNA isolation protocol is necessary in order to
retain sufficient DNA for microbiome research (Tedjo et al. 2015).
Swabs without any preservation medium can be regarded as
a special case of RT storage without buffer and consequently
contamination or overgrowth of aerobic species cannot be ex-
cluded. Because the sample is left to dry, transcriptomic and
metabolomic as well as culturing techniques are not possible in
this case. Dry swabs were the method of choice for the Ameri-
can Gut Project, one of the first large-scale faecal sampling ini-
tiatives.
Nucleic acid stabilising cards, such as the Flinders Technol-
ogy Associates (FTA) cards, stabilise DNA and RNA by trapping
the nucleic acids in the fibres of the card matrix after a lysis re-
action. Samples are collected by applying a thin layer of faeces
within the indicated region of the card. Although FTA cards have
been proven to sufficiently stabilise DNA for a broad range of ap-
plications (Smith and Burgoyne 2004; Mas et al. 2007), DNA yields
for faecal samples are low compared to other collectionmethods
(Nechvatal et al. 2008).
Multiple colon cancer screenings efforts make use of simi-
lar collection methods, namely faecal occult blood test (FOBT)
cards or tubes to detect blood in stool, one of the early-onset
markers of colon cancer. The sampling methods applied are of
particular interest, as they would open up additional large-scale
epidemiological research possibilities. Colon cancer screenings
usually apply either the guaiac-based FOBT (gFOBT) or faecal im-
munochemical Test (FIT), although high-sensitivity versions of
the latter are nowadays recommended (Leddin et al. 2010).While
there are several commercially available gFOBTs and FITs, most
adhere to a collection procedure in which three consecutive
samples are taken using a swab—either smeared onto a paper
card and allowed to dry or stored in a tube with haemoglobin-
stabilising buffer—and returned at RTwithin 2 weeks, usually by
mail. However, some protocols include additional steps, such as
dipping the swab into toilet water or storage in the fridge. In or-
der to detect blood in the samples both gFOBTs and FITs require
the application of reagents. The gFOBT, which is based on the
pseudo-peroxidase capacity of heme and its chemical reaction
with guaiac, requires a drop of a hydrogen peroxide containing
solution to initiate a colour conversion onto the paper, while FIT
tests mix part of the obtained sample solution with the anti-
human haemoglobin antibody reagent. Either the leftover of the
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buffer of the FIT or the developed cards could potentially be used
for microbiome analyses. However, on top of the high variability
in storage conditions, the use of study samples from colon can-
cer screening projects has some drawbacks worth considering.
First, the development solution of the gFOBT card and the sta-
bilisation buffer of the FIT tubemight cause additional diverging
effects on the observed microbiota composition. Second, the re-
quired modifications in diet (e.g. abstinence from red meat) and
medication (e.g. avoidance of NSAIDs) for the gFOBT test might
influence the results.
The applicability of both card and swab-based methods in
microbiome research is further limited by the small amount of
material collected. Given the heterogeneity of the stool matrix
and the increased effect of contamination, the latter magni-
fies sample processing errors. Moreover, small sample volumes
impose the development of adjusted DNA extraction protocols
(Tedjo et al. 2015), making results incomparable with all other
methods that do allow standard extraction techniques (Aagaard
et al. 2013). Evenwith proper stabilisation, the use of other omics
approaches would be restricted by the tiny amount of collected
material. Another drawback of these methods is the difficulty
to determine the weight of (part of) the sample. Assessment of
the initial weight is invaluable for all quantitative techniques
(e.g. metabolomics). The storage matrix and the tiny amounts of
sample collected using swab and card-based methods however
make determination of the initial weight impossible.
EFFECT OF PRESERVATION ON OBSERVED
MICROBIOTA COMPOSITION
Compared to the amount of ‘applied’ microbiome research pa-
pers, only a small number of technical studies have been pub-
lished regarding the effect of different sampling and storage
methods on microbial compositional profiles. The majority of
these studies are based on small-scale sampling of healthy
adults and might therefore miss or underestimate some effects,
limiting the generalisation of their results. For example, less sta-
ble or dysbiotic microbiota constellations, such as those of in-
fants or individuals with intestinal disease, might be affected
differently by storage conditions (Carroll et al. 2012; Guo et al.
2016). Although limited by their restricted population and sam-
ple sizes, these studies do provide important insights into the
divergent effects of temperature and stabilisation media over
time.
Cryopreservation
The current gold standard for long-term storage of faecal
samples—frozen at –80◦C storage without buffer—comes from
years of experience in tissue and culture preservation. It is sup-
ported by observations that microbiota composition, evaluated
by 16S RNA gene sequencing, does not change significantly over
4 weeks (Bai et al. 2012) or 6 months (Carroll et al. 2012) of stor-
age at –80◦C compared to samples extracted within 30 min after
egestion. Although Bahl et al. (2012) reported an increased Fir-
micutes/Bacteroidetes ratio in seven out of nine qPCR-assessed
samples, and Fouhy et al. (2015) and Flores et al. (2015) observed a
similar (though not significant) trend in short-term frozen sam-
ples, other studies with more samples and longer storage peri-
ods do not confirm these findings (Fouhy et al. 2015; Anderson
et al. 2016; Shaw et al. 2016). The effect of long-term freezing
on the faecal microbiota has been investigated by Shaw et al.
(> 2 years) and Kia et al. (> 14 years). Despite being sheared
more extensively than freshmaterial, high-quality DNA suitable
for 16S rRNA analyses could be recovered from these samples
(Kia et al. 2016). Long-term freezing seems to induce few sig-
nificant changes in microbial community, with a small reduc-
tion in the number of observed OTUs and shifts in some specific
abundances (notably increased Lactobacillus and Staphylococcus),
but similar alpha- and beta-diversitymeasurements, confirming
stability of the faecal microbiota during long periods of freezing
(Shaw et al. 2016).
Cryopreservation media are of standard use in axenic cul-
ture collections due to their ability to reduce cellular damage,
improving viability and activity recovery. Yet, only few studies
have been carried out to study their use in complex commu-
nities (Laurin et al. 2006; Vlaeminck et al. 2010; Hamilton et al.
2012; McKain et al. 2013;Waite, Deines and Taylor 2013; Kerckhof
et al. 2014), leaving their effect on the observed microbiota com-
position almost unassessed (McKain et al. 2013; Waite, Deines
and Taylor 2013; Kerckhof et al. 2014). Addition of the broadly
used cryoprotective agent DMSO did not markedly improve ac-
tivity recovery (as measured by SCFA production) in a study us-
ing faecal biomass, nor did it lead to any significant differences
in community composition compared to regular freezing (Ker-
ckhof et al. 2014). Although culturing will be the primary goal
of studies applying cryoprotective agents, the collected samples
can in theory also be used for omics technologies, making it
worthwhile to assess their effect on community composition.
Whether or not cryoprotection agents are applied, any thaw-
ing of samples should be avoided for downstream omics anal-
yses as it increases the chance of contamination and microbial
blooms, reduces DNA and RNA integrity due to nuclease activity
(Cardona et al. 2012; Santiago et al. 2014), and limitsmetabolomic
analyses because of the loss of volatile compounds (Kerckhof
et al. 2014) and the continuation of fermentation reactions (Grat-
ton et al. 2016). Freeze–thaw cycles have been shown to induce
changes in taxa abundance (Gorzelak et al. 2015; Song et al. 2016),
although limited (up to 4) and short (up to 10 min) cycles are re-
ported to have more robust profiles (Gorzelak et al. 2015). Longer
thawing periods however make subsequent metagenomic and
transcriptomic analyses less trustworthy as this severely re-
duces DNA and RNA quality: after 1 h of thawing, about 20%
of the DNA is fragmented into pieces smaller than 1.5 kb, and
RNA integrity numbers drop below 7, the threshold acceptable
for conducting metatranscriptomic studies (Cardona et al. 2012).
Other important points to consider when using cryopreser-
vation protocols are the time and storage conditions until freez-
ing as well as the freezing process itself. Short sampling times
and fast freezing processes, as applied in flash freezing with liq-
uid nitrogen, are ideal as all biological processes are put on hold
very quickly (Fouhy et al. 2015). Especially in the light of tran-
scriptomic and proteomic analyses, instant freezing provides
higher quality samples that are more likely to reflect the orig-
inal state of the sample (Flores et al. 2012; Fouhy et al. 2015).
In addition, culturing techniques would benefit of flash freez-
ing as cells suffer less damage than when frozen more slowly
(Fouhy et al. 2015). If cryopreservation cannot be initiated imme-
diately, overgrowth of aerotolerant bacteria can be avoided by
storing samples under anaerobic conditions, e.g. using gas paks
(Wehrspann 1976). Such approacheswould also benefit culturing
applications, as they increase the viability of anaerobic bacteria.
RT protocols
The effect of alternative protocols on microbiota composition
compared to freezing (Table 2) has been assessed in several
16S RNA gene-based studies. All of these report individual
variation to be larger than variation induced by the storage
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Table 2. Overview of reported significant effects of different storage conditions on alpha diversity measurements (richness, evenness, Shan-
non Diversity index (SDI)), beta diversity measurements (e.g. unifrac, Bray–Curtis dissimilarity (BC)) and taxa abundances in comparison to
immediate freezing (at –20◦C or –80◦C).
(Individual > storage) Individual variation is higher than variation due to storage, (≈) no difference, ( ) altered—but not specified in which direction, ( ) increased, ( )
decreased.
aTedjo et al. (2015); bChoo, Leong and Rogers (2015); cGratton et al. (2016); dCarroll et al. (2012); eGorzelak et al. (2015); fDominianni et al. (2014); gReck et al. (2015); hHale
et al. (2015); iFranzosa et al. (2014); jLoftfield et al. (2016); kSong et al. (2016); lAnderson et al. (2016); mGuo et al. (2016); nVogtmann et al. (2016); oSinha et al. (2015); pShaw
et al. (2016); qBlekhman et al. (2016); rHill et al. (2016).
conditions investigated. While RT storage without stabilisation
buffer significantly changes taxa abundances from 30 min on-
wards (Gorzelak et al. 2015; Sinha et al. 2015; Guo et al. 2016;
Shaw et al. 2016), refrigeration shows relatively unchanged mi-
crobial community profiles when limited to 24 h (Choo, Leong
and Rogers 2015; Tedjo et al. 2015). From these reports, it is also
clear that the use of preservation buffers to overcome the detri-
mental effects of RT storage is not always effective. Tris-EDTA
andRNAlater stored samples differ in taxa abundances and have
altered alpha-diversity measurements (conflicting results) after
72 h (Dominianni et al. 2014; Choo, Leong and Rogers 2015; Sinha
et al. 2015; Blekhman et al. 2016). The addition of antibiotics such
as kanamycin or ciproflaxin, which prevent RNA transcription or
protein translation, does not have any additional stabilising ef-
fects when added to RNAlater (Flores et al. 2015). Longer periods
of RT storage with RNAlater should definitely be avoided, as sta-
bility is seriously impaired after 2 weeks (Song et al. 2016).
Ethanol does not improve stability at 70% (Choo, Leong and
Rogers 2015; Sinha et al. 2015; Song et al. 2016) but seems to have
beneficial effects at 95%, providing similar alpha-diversity mea-
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surements after 24 h and only mild effects on community com-
position (Choo, Leong and Rogers 2015; Blekhman et al. 2016;
Song et al. 2016).
The RTTV OmniGeneGut is able to preserve faecal material
over a longer period of time, but suffers from consistent inad-
equate detection of Faecalibacterium and Bifidobacterium (Choo,
Leong and Rogers 2015; Hill et al. 2016). According to Anderson
et al. (2016), inter-replicate variation is less for OmniGeneGut
samples, which could be a consequence of the homogenisation.
Based on an evaluation of infant and elderly samples with clear
differences in richness, Hill et al. (2016) hypothesised that the
OmniGeneGut vials could have a larger influence on samples
with a lower diversity. The effect of storage for more than 60
days, either at RT or frozen, has not yet been established, leav-
ing unanswered questions regarding sample stability for those
studies demanding long-term storage.
The process of swabbing, using Cary-Blair medium and con-
ditions simulatingmail transport, was recently investigated, and
the results suggest that themethodmight inducesmost anoma-
lies: swab samples deviated most from their original subject-
specific cluster, compared to all other investigated methods, in-
cluding 24 h RT storage. Swab samples also showed increased
alpha-diversity and higher relative abundance of the taxa Ru-
minococcus and Enterobacteriaceae, while Methanobrevibacter—
despite its presence—was not picked up in any of the samples,
due to the dilution by the preservation medium, as suggested
by Tedjo et al. (2015). Swabs without preservation medium also
have profound effects on microbiota composition, with altered
abundances up to phylum level and changed alpha-diversity
measurements, severely impairing reproducibility (Sinha et al.
2015). The large differences in reproducibility and OTU profiles
between two labs performing similar DNA extraction protocols
as reported by Sinha et al. (2016) might also be partially caused
by a swabbing step applied by one of them.
FTA and FOBT tests make use of a swab sample smeared
on a card and allowed to dry (FTA and gFOBT) or stored in
haemoglobin stabilisation buffer (FIT). The swabbing procedure
combined with the prolonged exposure to fluctuating temper-
atures and oxygen likely induces similar or more pronounced
effects on microbiota composition as the earlier reported faecal
swabs. Song et al. compared samples stored with FTA cards to
fresh faecal samples and reported highly correlated OTU abun-
dance profiles over a range of storage conditions. Changes in
taxa abundance were not specified but seemed to be consis-
tent, as they could be corrected for using a detrending method
based on the mean fold change between abundances in fresh
and FTA stored samples. FTA cards tend to recover a greater di-
versity of bacterial taxa than other preservation methods, and
the authors suggest that this might be due to improved lyses
of spore-forming Firmicutes through the FTA card matrix. Yet,
contamination of the low-biomass sample seems a more likely
explanation.
The effect of FOBT tests on themicrobial compositionwas re-
cently explored by Sinha et al. (2015) and Vogtmann et al. (2016),
although under less harsh conditions as those expected to occur
during cancer screening. Both FIT and gFOBT bacterial profiles
are reported to differ significantly from the gold standard re-
garding technical reproducibility and stability (Vogtmann et al.
2016). Altered taxa abundances up to phylum level were ob-
served with more than 10-fold change in several OTUs (Sinha
et al. 2015; Vogtmann et al. 2016). Development of similarly stored
FOBT cards with Hemasensa developer, used to detect blood in
the stool sample during colon cancer screenings, induces little
variation, as OTU abundances highly correlated between pre-
and post-development samples (Sinha et al. 2015). Based on intr-
aclass correlation analyses of general parameters, such as phy-
lum abundance, alpha diversity and the first principal coordi-
nate of a beta diversity metric, the authors, however, rather sur-
prisingly, conclude that FOBT cards and FIT tubes are ‘acceptable
for future faecal sample collection inmicrobiome studies’ (Sinha
et al. 2015; Vogtmann et al. 2016).
What makes a preservation method acceptable?
While some of the methods discussed in the previous section
clearly show discrepancies from the original microbiota compo-
sition up to phylum level, theywere still described as ‘acceptable
for future microbiome studies’ by the reporting authors. This of
course raises the question as to what makes a method ‘accept-
able’. We will therefore discuss some of the essential features
and desirable aspects of storage methods for faecal samples in-
tended for microbiome research and assess how the methods
discussed relate to these criteria. First and foremost, the mi-
crobial signature of a sample needs to be preserved to such
extent that relevant conclusions can be drawn regarding the re-
search question. Second, key measures of gut microbiota com-
position must be stable and reproducible over time. Only after
due consideration of the points above, factors such as price, user
friendliness and ease of processing should be brought to the ta-
ble.
The most important criterion when selecting a preservation
method is the need to be able to draw relevant conclusions re-
garding the research question. Next to the accuracy of the ob-
tained data, this criterion obviously relates to the—expected—
effect size of the investigated and confounding parameters on
gut microbiome variation. Debelius et al. (2016) recently sorted
some already investigated parameters according to their contri-
bution to gut microbiota composition in animals and humans
and identified host species, age and lifestyle as parameters with
largest effect size, while antibiotic usewas classified asmedium,
and genetics, xenobiotics, exercise and long-term dietary pat-
terns were considered to have small-to-medium effects (Debe-
lius et al. 2016). Using the FGFP data, we were able to identify the
major covariates of gut microbiota composition in healthy indi-
viduals and estimated their non-redundant effect sizes between
0.5% and 5% (Falony et al. 2016). The identification of covariates
of microbiota composition is the first step in the search for a
causal link between gut microbiota and disease or suboptimal
health. However, it is becoming increasingly clear that the indi-
vidual contribution of such covariates is very small. This urges
microbiome researchers to be particularly careful in data acqui-
sition. Although the statement that preservation conditions do
not overcome differences between individuals is often made as
a sort of quality label in research articles comparing different
storage methods, procedures might easily mask the biological
influences investigated under the conditions applied. Indeed, in-
terindividual variation in microbiota composition is high, gen-
erally accounting for 50% to 80% of total variation and overrul-
ing all other explored parameters. Such assessments therefore
provide no idea whatsoever about the applicability of a certain
storage or transport method. What is needed is an estimation
of the effect size of the investigated storage condition in micro-
biome variation. However, none of the articles discussed in the
previous sections report this measure. It is therefore impossible
to know how much influence a preservation method has on the
gut microbiota composition or to compare its effect with that of
previously identified covariates. Consequently, it is very difficult
to assess whether or not a preservation method would allow to
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draw relevant conclusions regarding the research question. In
addition, one can only make guesses regarding the possibility to
conduct meta-analyses on cohorts with differently stored sam-
ples. Inclusion of effect size estimations of microbiome varia-
tion in future research articles investigating storage influences
would therefore certainly advance the field.
Depending on the estimated effect size of the investigated
parameter and the sample size, a certain degree of storage-
induced deviation from the original microbiota composition can
be allowed. It is however important to keep in mind the spe-
cific deviations induced by the considered protocols. Indeed,
a procedure generating random noise is a whole lot different
from one inducing specific alterations in taxa abundances or
diversity estimates. An altered detection of key species might
for example lead to a bias in disease research. The increased
abundance of Proteobacteria reported in samples stored with
Tris-EDTA buffer (Choo, Leong and Rogers 2015), OmniGeneGut
RTTVs (Choo, Leong and Rogers 2015), faecal swabs (Tedjo et al.
2015) or FOBT cards (Sinha et al. 2015)—which are thought to be
a result of the aerobic storage conditions—is particularly wor-
risome given the resemblance of these changes with some re-
ports of diet-induced variation or disease-associated dysbiosis
(Frank et al. 2011; Mondot et al. 2011; Wu et al. 2011; Le Chatelier
et al. 2013). Faecalibacterium, Bifidobacterium and Verrucomicro-
bia (comprising Akkermansia) are other important taxa related
to health status that are regularly reported to differ from the
gold standard. Especially in those cases where first assumptions
about signature species can be derived from previous studies,
the choice of a suited preservation method should be addressed
accordingly. In this regard, we want to point out the importance
of precise and clear reporting of method comparison studies.
As they form a guideline for future work, researchers conduct-
ing such studies have the responsibility to report the observed
effects regarding genera abundance in a clear and transparent
manner. Only reporting phylum level variation or limiting de-
scription to those bacteria with a more than 10-fold change in
abundance instead of assessing the significance of differences
between groups is inadequate, as biological relevant signals can
be situated at genus or even species level and are often far
<100%. In order to correct abundance tables for the overgrowth
of aerotolerant bacteria, mostly Gammaproteobacteria, compu-
tational approaches have been suggested (Song et al. 2016). How-
ever, assessing the accuracy of such correction methods is dif-
ficult and consequently the obtained data are highly uncertain,
making such practices of little use for studies aiming to charac-
terise the impact of low-effect-size factors on the gutmicrobiota.
Despite the lack of information regarding the explained vari-
ance of preservation methods on gut microbiome variation,
some general recommendations to fulfil the criterion described
above can be made. Obviously, the effect of preservation is con-
tainable when a single method is applied throughout a study.
Many authors report significant differences between the inves-
tigated storage methods (Sinha et al. 2015; Song et al. 2016; Vogt-
mann et al. 2016), and therefore the application of multiple stor-
age methods within a study is unadvisable. In order to control
the diverging effect of collection and storage further, protocols
should be specified in detail and followed as strictly as possi-
ble. These and all measures reducing technical variation due to
preservation are a good way to diminish the effect of storage
conditions on the observed microbiota composition, whatever
the initial accuracy level of the procedure.
A second important point regards the stability and repro-
ducibility of key measures of gut microbiota composition over
time. Whatever the effect size of the considered parameter on
gut microbiome variation, major markers of gut microbiome re-
search (including diversity indexes, community types or phy-
lum abundance) should not differ significantly between techni-
cal replicates. Given the relative stability of suchmarkers within
an individual (Wu et al. 2011; Yatsunenko et al. 2012; Donaldson,
Lee and Mazmanian 2015), not fulfilling this condition would
most probably lead to invaluable conclusions. Most of the meth-
ods describedmeet this minimal requirement (Dominianni et al.
2014; Flores et al. 2015; Sinha et al. 2015; Anderson et al. 2016; Hill
et al. 2016; Song et al. 2016; Vogtmann et al. 2016), although swab
and card-based techniques might form an exception, especially
with prolonged storage times (Sinha et al. 2015; Vogtmann et al.
2016). Of note, technical reproducibility of most methods apply-
ing RT storage diminishes with the time of preservation (Sinha
et al. 2015; Tedjo et al. 2015; Anderson et al. 2016; Hill et al. 2016;
Song et al. 2016).
Only when the microbial signature of a sample can be pre-
served to such extent that relevant conclusions can be drawn re-
garding the research question and the obtained data have been
shown stable and reproducible over time, other aspects of stor-
agemethods can be taken into account. Definitely worth consid-
ering are the applicability of standard protocols, which opens up
perspectives for meta-analyses, and the possibility for biobank-
ing, which would reduce the cost of follow-up research.
USER EXPERIENCE OF FAECAL SAMPLING AND
FACTORS AFFECTING DROP-OUT
Keeping participantsmotivated throughout a study is a demand-
ing task in every research project, but is believed to be evenmore
critical in colonmicrobial research given the possible reluctance
for faecal sampling. Despite the long track record of faecal sam-
pling for gastrointestinal research, there is almost no informa-
tion available regarding sampling aversion or protocol prefer-
ence and how this affects protocol adherence. Without such in-
formation, there is no use in discussing different protocols for
microbiome research on user experience, nor can any conclu-
sions be drawn regarding the importance of this aspect and the
weight it should get when selecting a suitable samplingmethod.
To gain more insight on the user experience of the faecal
sampling process, we set up an evaluation of the sampling pro-
cedures of the FGFP. In order to collect high-quality samples
for microbiome research, the FGFP asked participants to imme-
diately freeze their sample into their home freezer and estab-
lished a permanent collection network of 60 pharmacies across
the densely populated region of Flanders, ensuring a collection
point within 10 km driving distance of each participant’s home
address. A first large-scale collection round used this network
together with frequent pharmacy-to-laboratory transport on dry
ice to collect all faecal samples delivered during a 12-week pe-
riod. In total, 3083 individuals, of whom one third can be re-
garded healthy, completed all sampling procedures.
Why do people drop-out?
During the first FGFP sampling round, 4837 sampling kits were
sent to project participants—64% of the addressed volunteers
completed the FGFP sampling protocol. To investigate reasons
for (lack of) compliance to the FGFP sampling procedure, a link
to an evaluation questionnaire was mailed to 500 subscribed
volunteers, randomly selected out of all people who received
a sampling kit during the first sample collection round and
independent of their final decision to participate. Among the 267
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Figure 1. Importance of different features of a faecal sampling procedure. Vol-
unteers were asked to rank six different aspects of the sampling procedure from
most important to least important. The figure represents the percentage of peo-
ple that ranked the feature (y-axis) at a certain level of importance (x-axis). The
total score of each feature is given next to its distribution.
responders, 21 indicated not having delivered the samples re-
quired. Before registering as FGFP volunteers, potential project
participants were informed of the necessity of faecal sampling.
Because of the applied awareness policy, none of the responders
reported that their decision to renounce from further participa-
tion was related to the actual sampling procedure, and only 5%
of those completing the full protocol indicated having thought
about quitting because of sampling aversion. Most cited reasons
for renouncing to participation were the burden of scheduling a
GP consultation (20%) and the impossibility of completing pro-
cedures within the sampling round timeframe proposed (33%).
Although people are not informed upfront that project partic-
ipation required the storage of faecal samples into their home
freezer, only 2.8% of respondents indicated it to be a reason for
quitting the project.
How big is the ‘yuck-factor’?
When asked for sampling preferences, 56% of effective partici-
pants indicated they would opt for a protocol allowing to com-
plete procedures in proximity of the toilet. Most important as-
pects of faecal sampling procedures were indicated to be (i) the
instructiveness of the sampling manual, (ii) sampling hygiene
and (iii) straightforwardness of sample handling (Fig. 1). Surpris-
ingly, FGFP participants value a clear description of the required
sample handlings over all other factors that could increase user
experience. A higher certainty that one performed the sampling
correctly, which—based on the reactions in the opinion box—
seems to be important for most participants, might explain this
result. As FGFP participation is voluntarily, this feeling might be
less present in other studies. Nevertheless, it is clear that per-
sonal aversion from faecal sampling is probably less important
than commonly assumed.
In the case of the FGFP, people were instructed by the sam-
plingmanual to collect their sample using a self-provided basket
covered with the biodegradable, flushable plastic sheet included
in the sampling package. On completion of the collection of their
stool sample, they were asked to fill three small plastic transpar-
ent tubes with about 1 cm of stool using three provided plastic
spoons. They could cut off the plastic spoons with a scissor (not
provided) and leave the rest in the tube, so that they would not
be left with stool-covered waste. The rest of their stool could be
flushed through the toilet using the biodegradable plastic.
Instructiveness of the samplingmanual included in FGFP kits
was scored (almost) completely clear by 93% of participants.
All participants indicated having read sampling instructions be-
fore (69%) or during (31%) procedures. While about two-thirds
of volunteers judged the sampling procedure as ‘very to rea-
sonably hygienic’, 15% scored it at the low end of the hygiene
scale. Suggestions to improve sampling hygiene concerned the
use of wider collection tubes (present diameter: 1 cm) and more
rigid sampling spoons. Overall, FGFP sampling procedures were
judged uncomplicated and about 90% of the participants did
not object to the use of own materials (such as a collection re-
cipient and scissors). Most cited inconvenience (30%) was the
difficulty to comply with the FGFP requirement to deliver a
urine-free sample, which, for obvious anatomical reasons, ap-
pearsmore problematic for women (36%) thanmen (19%). About
24% of volunteers reporting this issue were not able to take a
urine-free sample at the first attempt. As the sampling manual
clearly stated the importance of delivering a urine/toiletwater-
free sample, 10 out of 13 participants repeated the sampling pro-
cedure. However, the latter indicates that up to 1.3% of samples
collected are urine-contaminated—with currently unassessed
impact on the faecal microbiome.
The faecal sampling procedure as implemented by the FGFP
was evaluated positively by most participants. Two-thirds of
the volunteers who registered for FGFP participation effectively
completed all procedures. Microbiome monitoring efforts using
a similar sample collection protocol should hence take into ac-
count drop-out ratios of about 40%. In part due to an active
awareness policy—participants can consult the sampling man-
ual on the FGFP website prior to registration—no volunteers re-
nounced from effective participation based on the actual sam-
pling handlings. As<5% of people indicated thoughts of quitting
related to the faecal sampling procedure or the requirement of
sample storage in the home freezer, we can assume the drop-out
ratio ofmicrobiome research studies is not heavily influenced by
faecal sampling user experience. In this regard, extending the
collection network or organising multiple collection rounds—
reportedly themain hurdles to complete the sampling process—
would probably be more effective ways to decrease this ratio in
similar set-up projects. Nevertheless, participants do appreciate
a simple and hygienic sampling procedure. Although improve-
ments on this front would without doubt improve user experi-
ence, we discovered that evenmore could be gained from a clear
sampling manual. The data of the FGFP evaluation thus enable
us to deduce some general recommendations, yet our conclu-
sions are obviously based on a single study and might not be
applicable in different circumstances.
COST AND TIME EFFICIENCY OF
PRE-PROCESSING
To scale up microbiota research projects to the extent and dura-
tion required, automation of sample handling, DNA extraction
and sequencing preparation seem essential in order to keep mi-
crobiome monitoring efforts both time and cost-effective. How-
ever, resource management might benefit even more from the
optimisation of the pre-processing pipeline. We will therefore
discuss budget and time investment of several logistic options
for faecal sampling.
Before starting DNA/RNA extraction or any other experimen-
tal work for microbiome research, a standard protocol for fae-
cal sampling for microbiome research can be divided into three
main steps: collection, transport and aliquoting of the sample.
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Table 3. Comparison of the different aliquoting methods for a study collecting 10 000 samples.
Box 1. Current options for faecal sample collection.
Large-scale projects applying these collection methods: aFlemish Gut Flora Project, Falony et al. (2016). bHuman Microbiome Project (2012). cAmerican Gut
(http://www.americangut.org). dSYSCID (www.syscid.eu). Fecotainer is a basket that can be placed under the toilet seat to collect the faecal sample after egestion.
In order to store the sample, the Fecotainer can be sealed with a stopper and lid. (www.fecotainer.eu) Divimat is a silicon mat with little holes, the size of an ideal
aliquot for DNA extraction. Instructions are printed onto a transparent plastic sticker covering the device except for the holes. Participants use a rigid plastic card to
smear a small part of their sample into the holes. When all holes are filled, they remove the transparent plastic cover, leaving a clean surface. A barcoded sealing
sticker is glued onto the surface of the device before freezing, providing protection and labelling.
Because only a small part of the sample is needed for sub-
sequent protocols, aliquoting is an important step within the
pre-processing. Off course, these steps are all influenced by the
choice of preservation method. Opting for a specific method for
one aspect limits the available options for the others. Because
collection and aliquoting are very intertwined, we will first dis-
cuss cost- and time efficiency of different combinations of these
two steps and then take a closer look at transport logistics. In or-
der to illustrate the impact of the different options on large-scale
faecal sampling, we will use a study collecting 10 000 samples as
an example.
Collection and aliquoting
While aliquoting is very straightforward for most RT methods,
it can be quite complicated for freezing protocols. Either cut-
ting or drilling a frozen faecal sample is a very laborious, ex-
pensive and time-consuming process. However, new devices im-
plementing the principle of aliquoting before freezing—right af-
ter collection—were developed recently (e.g. DiviMat (our lab)).
Therefore, we can now distinguish three main aliquoting op-
tions: (i) aliquoting after RT storage, (ii) aliquoting after freezing,
(iii) aliquoting before freezing (Table 3).
Based on our own experience with the discussed methods,
we estimate the time spend on aliquoting to increase with a
factor 9 when it needs to be done after freezing of the sam-
ple. In case of our example study, methods implementing RT
aliquoting—either before freezing or after RT storage—would re-
quire only 22 working days, while methods requiring aliquoting
after freezing would easily take more than 200 working days.
Not surprisingly, for the latter the cost associated to downstream
processing is largely determined by the cost of labour, and can
go up to 70%, depending on the collection method. In contrast,
total budget for protocols able to aliquot at RT highly depends
on the price of the collection method, as this can range from
€0.3 to €20 (Box 1). The most time-efficient methods are thus
without doubt those that perform the aliquoting at RT, but cost-
efficiency depends largely on the collection device used.
Transport
For transport logistics, we distinguish five main transport plans:
(i) immediate sampling on location, (ii) home sampling without
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freezing and regular mail or courier delivery (e.g. American Gut),
(iii) home samplingwith freezing with a courier transporting the
samples from the participant’s place to the lab (e.g. Life Lines
Deep (Tigchelaar et al. 2015)), (iv) home sampling with freezing
using onemoving collection point where participants bring their
samples, (v) home samplingwith freezing usingmany collection
points together with a courier service (e.g. FGFP).
In densely populated areas with an easily accessible labora-
tory, participants could come to the lab and sample on location.
While it is difficult to estimate the compensation required for
such an effort, it is clear that the transportation costs of the
participant can be used as a guideline. Although highly depend-
ing on the situation, we will therefore take into account a reim-
bursement cost of €15 per sample for our example study, bring-
ing the total budget for transport in this case on €150 000.
The second option, regular or express mailing, is currently
the cheapest and quickest way of transporting faecal samples.
Protocols making use of swabs, FTA cards RTTV or tubes with
non-hazardous buffers stored at RT would be able to do so and
spend about €2.5 per sample to receive it within three working
days. Transport of 10 000 samples would therefore cost about
€25 000. While the usage of regular mailing companies has the
advantage of being inexpensive and easy implementable across
large geographic distances, it has the disadvantage of an un-
controlled transport chain where temperature profiles depend
on transport conditions, which can vary substantially across re-
gions and seasons. Consequently, samples might be subjected
to high temperatures or freeze (and thaw) during transport.
All other transport plans discussed here make use of a freez-
ing step and thus require adequate cold-chain management.
Based on an evaluation of FGFP procedures, we make sugges-
tions on how to achieve this (Box 2).
Box 2 Cold-chain management
Based on an evaluation questionnaire, we estimate that 97%
of collected FGFP samples are frozenwithin 5min after sam-
pling. On average, samples are stored in a home freezer
for 2 days and 6 h before transport to a collection point.
Around 85% of participants indicated an estimated trans-
port time below 30 min. In order to maintain samples in
frozen condition during transport—as explicitly stated in
the sampling manual—participants report to use a cooling
box with cooling elements (67%), ice cubes (6%), an isolat-
ing bag/box (18%) or a cooling box (6%). Although 5% of the
volunteers indicated not to have cooled nor isolated the
samples, this does not necessarily imply thawing, given the
short transport times. In addition to the questionnaire, lon-
gitudinal temperature profiles of 137 complete sampling-
storage-transport processes were collected. On average, the
whole sampling procedure takes 8 days and 16 h. A total of
13 out of 137 samples (9%) got defrosted once. Most thawing
events occurred during transport from the volunteer’s home
to the collection point; however, one appeared to be due to
an inadequate defrosting cycle of the home freezer. Thaw-
ing time of these samples varied between 5 and 50 min. So
although most FGFP participants demonstrate their inven-
tiveness to maintain samples in frozen conditions, around
23% opt for minor isolation, and transport from the home
freezer to FGFP collection points seems a crucial step, with
about 10% of samples at risk of thawing. As 23% opt for mi-
nor isolation, providing a cooling cover, which participants
can wrap around their samples upon freezing, would most
probably decrease this number drastically. As most thawing
events occur during transport of the sample, a decreased
average distance to the collection point could not only be
a remedy for volunteer drop-out, but also a way to limit
thawing risk. In order to check on thawing events, a logging
device could be added to the sampling package. Currently,
there are user-friendly thawing-sensitive strips that indi-
cate a thawing event by colour change available for about
€1. Simple visual inspection at the moment of arrival by
the lab technician is then enough to identify thawed sam-
ples.
A transport plan using home sampling with freezing with a
courier transporting the samples from the participant’s place to
the lab has been applied by Life Lines Deep, and is estimated to
cost about €60 per sample. In this case, total cost for transport
in our example study would be about €600 000.
Althoughwe do not know any application of the fourth trans-
port plan, home sampling with freezing using one moving col-
lection point which is located close to the participants home so
that they can bring their samples would be an option for co-
horts recruitingwithin a restricted geographical region. The cost
of this collection effort largely depends on the duration of the
sampling scheme and the distance that needs to be covered.
When we estimate the cost of a van, dry ice and driver/collector
at about €500 a day, sampling a 60-point collection network
with 5-day stays would take more than a year and cost about
€150 000. With large home–collection point distances, reim-
bursement of transport costs might need to be implemented,
but we did not include this into our estimation. With some ad-
ditional scheduling efforts, such a transport plan could be com-
bined with medical examination on location. However, short
sample collection stays and large home–collection point dis-
tances require a lot of flexibility from the study participant and
might thus increase drop-out.
Lastly, home sampling with freezing using many collection
points together with a courier service has been applied by our
lab for the FGFP. In short, wemade use of a permanent collection
network of 60 local pharmacies equipped with a FGFP freezer,
where study participants could deliver their frozen samples dur-
ing a specified time frame. During the collection period, samples
were transported twice a week on dry ice (–70◦C) from the col-
lection point to the laboratory, where they were stored at –80◦C
until further analysis. Initial installation costs of such a network
are about €9000, while maintenance takes about €3000. Phar-
macies are compensated for their role in the logistic chainwith a
fee of €2 per sample. One of the largest expenses is the collec-
tion point—laboratory transport, which costs about €6500 per
collection round covering the complete network. Implementing
such a protocol from scratch for 10 000 different samples would
thus cost between €58 000 and €136 000 depending on the time
frame of the sampling period (2 weeks versus 2 months).
With these data, it is clear that time and cost-efficiency of a
complete pre-processing pipeline—including collection, trans-
port and aliquoting—are at this moment no longer determined
by whether or not cryopreservation is applied.
While RT protocols applying swabs would in theory be able
to collect, transport and aliquot 10 000 samples for as little as
± €35 000 using regular mail transport, stabilizing these sam-
ples using an RTTV such as OmniGeneGut would raise the price
of such a study to ± €207 000. In comparison, a pre-processing
protocol implementing DiviMat together with a transport plan
based on a collection network, would cost between €138 000
and €198 000 depending on the collection period (2 weeks
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versus 2months) (Box 1). Although transport generally takes the
lion share of total pre-processing costs, all three steps (collec-
tion, transport or aliquoting) can be the main determinant of
cost-efficiency in this stage; it all depends on the applied combi-
nation. In contrast, time efficiency of a complete pre-processing
pipeline is mainly determined by whether stool samples are di-
vided into aliquots at RT or not, as cutting or drilling a frozen
sample takes almost a 10-fold of the time (Table 3).
FUTURE PERSPECTIVES
Given the small effect size of biologically relevant parameters
on gut microbiota composition, discovery research in the gut
microbiome field is bound to use collection and preservation
methods rendering samples that reflect the original microbiota
composition as closely as possible. At this moment, highest
sample quality for omics techniques assessing the faecal micro-
biota can only be obtained with cryopreservation. Future micro-
biome research would thus largely benefit from improvements
in cold-chain management and cost- and time efficiency of pro-
tocols implementing this gold standard. This wouldmake it pos-
sible to obtain the large number of high-quality samples re-
quired for discovery research faster and with fewer resources.
Yet, even with advancements in freezing protocols, cryopreser-
vation might not be possible in certain circumstances. The de-
velopment of RT preservation methods that induce less devia-
tion from the original microbiota composition and/or would al-
low additional omics techniques would therefore also enhance
the field. Especially in the light of targeted studies or follow-up
work, such methods might then provide a decent alternative to
cryopreservation. However, clear reporting of method compari-
son studies, with the inclusion of effect size estimations when-
ever possible, is key in order to make quality assessments and
determine whether a method would be suitable to address the
research question. Yet, method comparisons are still underre-
ported and effect size information is almost completely unavail-
able. Time will hopefully change this and enable us to takemore
informed decisions on sample preservation methods. Increased
availability of the necessary information for quality assessment
together with improvements in sample pre-processing would
certainly facilitate the set up and handling of large-scale gut mi-
crobiome studies and would beneficially affect the consistency
of their results. Initiatives tackling either of these points would
therefore be of great interest to the gut microbiome field and be-
yond.
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